Literature DB >> 19464398

An 8.35 Mb overlapping interstitial deletion of 8q24 in two patients with coloboma, congenital heart defect, limb abnormalities, psychomotor retardation and convulsions.

J B G M Verheij1, S A de Munnik, T Dijkhuizen, N de Leeuw, D Olde Weghuis, G J van den Hoek, R S Rijlaarsdam, Y E M Thomasse, F G Dikkers, C L M Marcelis, C M A van Ravenswaaij-Arts.   

Abstract

Chromosome analysis in two young patients with multiple congenital anomalies revealed a de novo interstitial deletion of 8q that has not been reported before. The deletions were overlapping by 8.35 Mb (8q24.21q24.23). The clinical features shared by our patients were coloboma, VSD, digital abnormalities, congenital dislocation of a hip, feeding problems, psychomotor delay and convulsions. The deletion included the region for Langer-Giedion syndrome (TRPS1 and EXT1) in the girl only. However, she is too young to present features of this syndrome, apart from dysmorphic features like a bulbous nose and notched alae nasi. Several genes are present in the commonly deleted region, including genes with unknown function, and genes for which haploinsufficiency is known to have no phenotypic effect in mice (Wnt1). A gene that might play a role in the convulsions of our patients is KCNQ3.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464398     DOI: 10.1016/j.ejmg.2009.05.006

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  18 in total

1.  SCRIB and PUF60 are primary drivers of the multisystemic phenotypes of the 8q24.3 copy-number variant.

Authors:  Andrew Dauber; Christelle Golzio; Cécile Guenot; Francine M Jodelka; Maria Kibaek; Susanne Kjaergaard; Bruno Leheup; Danielle Martinet; Malgorzata J M Nowaczyk; Jill A Rosenfeld; Susan Zeesman; Janice Zunich; Jacques S Beckmann; Joel N Hirschhorn; Michelle L Hastings; Sebastien Jacquemont; Nicholas Katsanis
Journal:  Am J Hum Genet       Date:  2013-10-17       Impact factor: 11.025

2.  An 11.4-Mb Interstitial Deletion in a Fetus with No Apparent Phenotypic Alterations.

Authors:  Paolo Guanciali-Franchi; Claudio Celentano; Melissa Alfonsi; Chiara Palka; Giulietta Di Pasqua; Barbara Matarrelli; Giandomenico Palka
Journal:  Mol Syndromol       Date:  2016-12-03

3.  Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature.

Authors:  Salima El Chehadeh; Wilhelmina S Kerstjens-Frederikse; Julien Thevenon; Paul Kuentz; Ange-Line Bruel; Christel Thauvin-Robinet; Candace Bensignor; Hélène Dollfus; Vincent Laugel; Jean-Baptiste Rivière; Yannis Duffourd; Caroline Bonnet; Matthieu P Robert; Rodica Isaiko; Morgane Straub; Catherine Creuzot-Garcher; Patrick Calvas; Nicolas Chassaing; Bart Loeys; Edwin Reyniers; Geert Vandeweyer; Frank Kooy; Miroslava Hančárová; Marketa Havlovicová; Darina Prchalová; Zdenek Sedláček; Christian Gilissen; Rolph Pfundt; Jolien S Klein Wassink-Ruiter; Laurence Faivre
Journal:  Eur J Hum Genet       Date:  2016-11-02       Impact factor: 4.246

4.  Identification of a New Variant of PUF60 Gene: Case Presentation and Literature Review.

Authors:  Daniela Oana Toader; Nicolae Bacalbasa; Radu Ursu; Dragos Cretoiu; Lucian G Pop; Irina Balescu; Florentina Gherghiceanu; Florentina Furtunescu; Daniel Radavoi; Viorica Radoi
Journal:  Cancer Diagn Progn       Date:  2021-07-03

5.  Neuron-Specific Deletion of Scrib in Mice Leads to Neuroanatomical and Locomotor Deficits.

Authors:  Jerome Ezan; Maité M Moreau; Tamrat M Mamo; Miki Shimbo; Maureen Decroo; Nathalie Sans; Mireille Montcouquiol
Journal:  Front Genet       Date:  2022-05-25       Impact factor: 4.772

6.  Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.

Authors:  Kazuyuki Matsushita; Kouichi Kitamura; Bahityar Rahmutulla; Nobuko Tanaka; Takayuki Ishige; Mamoru Satoh; Tyuji Hoshino; Satoru Miyagi; Takeshi Mori; Sakae Itoga; Hideaki Shimada; Takeshi Tomonaga; Minoru Kito; Yaeko Nakajima-Takagi; Shuji Kubo; Chiaki Nakaseko; Masahiko Hatano; Takashi Miki; Masafumi Matsuo; Masaki Fukuyo; Atsushi Kaneda; Atsushi Iwama; Fumio Nomura
Journal:  Oncotarget       Date:  2015-03-10

Review 7.  Update on the implication of potassium channels in autism: K(+) channelautism spectrum disorder.

Authors:  Luca Guglielmi; Ilenio Servettini; Martino Caramia; Luigi Catacuzzeno; Fabio Franciolini; Maria Cristina D'Adamo; Mauro Pessia
Journal:  Front Cell Neurosci       Date:  2015-03-02       Impact factor: 5.505

8.  PUF60 variants cause a syndrome of ID, short stature, microcephaly, coloboma, craniofacial, cardiac, renal and spinal features.

Authors:  Karen J Low; Morad Ansari; Rami Abou Jamra; Angus Clarke; Salima El Chehadeh; David R FitzPatrick; Mark Greenslade; Alex Henderson; Jane Hurst; Kory Keller; Paul Kuentz; Trine Prescott; Franziska Roessler; Kaja K Selmer; Michael C Schneider; Fiona Stewart; Katrina Tatton-Brown; Julien Thevenon; Magnus D Vigeland; Julie Vogt; Marjolaine Willems; Jonathan Zonana; D D D Study; Sarah F Smithson
Journal:  Eur J Hum Genet       Date:  2017-03-22       Impact factor: 4.246

9.  High-resolution chromosomal microarray analysis for copy-number variations in high-functioning autism reveals large aberration typical for intellectual disability.

Authors:  Anna Maria Werling; Edna Grünblatt; Beatrice Oneda; Anita Rauch; Susanne Walitza; Elise Bobrowski; Ronnie Gundelfinger; Regina Taurines; Marcel Romanos
Journal:  J Neural Transm (Vienna)       Date:  2019-12-14       Impact factor: 3.575

10.  Dysfunction of the Heteromeric KV7.3/KV7.5 Potassium Channel is Associated with Autism Spectrum Disorders.

Authors:  Mette Gilling; Hanne B Rasmussen; Kirstine Calloe; Ana F Sequeira; Marta Baretto; Guiomar Oliveira; Joana Almeida; Marlene B Lauritsen; Reinhard Ullmann; Susanne E Boonen; Karen Brondum-Nielsen; Vera M Kalscheuer; Zeynep Tümer; Astrid M Vicente; Nicole Schmitt; Niels Tommerup
Journal:  Front Genet       Date:  2013-04-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.